M & As this week: Woden Venture Capital, Evotec

Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics for C$4.5m ($3.6m).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news